Impact of specialist care in patients with newly diagnosed heart failure

Impact of specialist care in patients with newly diagnosed heart failure: a randomised controlled study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN16302432

Enrollment

114

Registered

2005-09-07

Start date

2002-06-06

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure Circulatory System Heart failure

Interventions

Management in a specialist heart failure clinic with regular follow up by heart failure nurses versus usual care. All patients were followed up for a minimum of 3 months post-randomisation with a mean

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients (adults, either sex) with suspected heart failure referred for an open access echocardiogram.

Exclusion criteria

Exclusion criteria: Patients with previously confirmed left ventricular systolic dysfunction on echo.

Design outcomes

Primary

Measure	Time frame
Optimum prescription of medication for heart failure including angiotensin-converting enzyme (ACE) inhibitors, Angiotensin receptor blockers, beta blockers and spironolactone.	—

Secondary

Measure	Time frame
Composite endpoint of all cause mortality and/or hospitalisation.	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026